Evidence Based Guideline: Fecal Microbiota Transplant (FMT) for the Treatment of Clostridiodes (Clostridium) Difficile Infection

Brief Description: Clostridium difficile is the most common cause of healthcare-associated diarrhea and recurs in anywhere from 12 to 64% of patients. C. difficile infection (CDI) is usually managed with antibiotics; however, severe disease may be refractory to medication therapy. Fecal microbiota transplant (FMT) has been evaluated as an alternative treatment modality in the management of severe medication-refractory and recurrent CDI (RCDI). The guideline outlines steps necessary to ensure that the process of FMT is both safe and efficient for patients at OSUWMC.

Variants
Price
$100.00